Reference figures for business scale in pharmaceuticals, nursing care and childcare, and third-quarter results
First written in FY2022-Q3. 2 of 13 entries say "Advanced", first in FY2022. Latest entry: FY2026.
52 other companies' latest entry also says "Other".
- FY2026Updated full-year performance, number of locations and KPIsAnnual report
「As a result, revenue was ¥24,850 million, up 4.3% year on year; operating profit was ¥824 million, up 28.6%; ordinary profit was ¥827 million, up 28.4%; and net profit attributable to owners of the parent was ¥200 million, down 33.0%.」
Full-year results were updated. Revenue, operating profit and ordinary profit increased, while net profit attributable to owners of the parent declined due to impairment losses and other factors. At fiscal year-end, the company had 45 dispensing pharmacies, 78 childcare-support facilities and 61 care facilities. - FY2026-H1Interim results and facility-count figures updatedAnnual report
「As a result, revenue was ¥11,989 million, up 4.3% year on year; operating profit was ¥193 million, up 55.1%; ordinary profit was ¥197 million, up 63.8%; and interim net profit attributable to owners of the parent was ¥139 million, up 25.0%. As of the end of the interim consolidated fiscal period, the company had 45 dispensing pharmacies, 79 operating childcare facilities and 62 care facilities.」
Interim results, facility counts and segment sizes were updated. Revenue and profit exceeded the same period of the previous year, and the company had 45 dispensing pharmacies, 79 childcare-support facilities and 62 care facilities. - FY2025Updated full-year performance, number of locations and KPIsAnnual report
「Revenue was ¥23,825 million, up 4.9% year on year; operating profit was ¥641 million, up 62.2%; ordinary profit was ¥644 million, up 72.3%; and net profit attributable to owners of the parent was ¥299 million, up 5,320.9%. As of the end of the consolidated fiscal year, the company had 43 dispensing pharmacies, 77 operating facilities and 63 care facilities.」
Full-year results and the number of facilities were updated. Revenue and profit increased, while the number of care facilities declined by 2 from the end of the previous fiscal year. - FY2025-H1Updated performance and number of locationsAnnual report
「As a result, revenue was ¥11,498 million, up 4.6% year on year; operating profit was ¥124 million, up 399.8%; ordinary profit was ¥120 million, up 494.0%; and interim net profit attributable to owners of the parent was ¥111 million. As of the end of the interim consolidated fiscal period, the company had 43 dispensing pharmacies, 79 operating childcare facilities and 65 care facilities.」
For the interim period, revenue was ¥11,498 million, operating profit was ¥124 million, ordinary profit was ¥120 million and interim net profit attributable to owners of the parent was ¥111 million. The company had 43 dispensing pharmacies, 79 childcare-support facilities and 65 care facilities. - FY2024-Q3Updated performance and number of locationsAnnual report
「As a result, revenue was ¥16,886 million, up 2.1% year on year; operating profit was ¥277 million, up 613.3%; ordinary profit was ¥275 million, up 2,199.1%; and quarterly net profit attributable to owners of the parent was ¥117 million, compared with a quarterly net loss attributable to owners of the parent of ¥58 million in the same period of the previous year. As of the end of the third quarter of the current consolidated fiscal year, the number of dispensing pharmacy outlets was 42, unchanged from the end of the previous consolidated fiscal year. The number of care facilities was 67, unchanged from the end of the previous consolidated fiscal year. The number of operating childcare facilities was 78, an increase of 4 from the end of the previous consolidated fiscal year.」
For the nine months ended in the third quarter, revenue was ¥16,886 million, operating profit was ¥277 million, ordinary profit was ¥275 million and net profit attributable to owners of the parent was ¥117 million, returning to profitability from a net loss in the same period of the previous year. The company had 42 dispensing pharmacies, 67 care facilities and 78 operating childcare facilities. - FY2024-Q2Updated performance and number of locationsAnnual report
「As a result, revenue was ¥10,993 million, up 0.6% year on year; operating profit was ¥24 million, up 236.5%; ordinary profit was ¥20 million, compared with an ordinary loss of ¥11 million in the same period of the previous year; and quarterly net loss attributable to owners of the parent was ¥32 million, compared with a quarterly net loss attributable to owners of the parent of ¥44 million. As of the end of the second quarter of the current consolidated fiscal year, the number of dispensing pharmacy outlets was 42, unchanged from the end of the previous consolidated fiscal year. The number of care facilities was 67, unchanged from the end of the previous consolidated fiscal year. The number of operating childcare facilities was 78, an increase of 4 from the end of the previous consolidated fiscal year.」
For the six months ended in the second quarter, revenue was ¥10,993 million, operating profit was ¥24 million and ordinary profit was ¥20 million, while quarterly net loss attributable to owners of the parent was ¥32 million. The company had 42 dispensing pharmacies, 67 care facilities and 78 operating childcare facilities. - FY2024-Q1Updated performance and number of locationsAnnual report
「As a result, revenue was ¥5,475 million, down 0.2% year on year; operating loss was ¥26 million, compared with an operating loss of ¥13 million in the same period of the previous year; ordinary loss was ¥27 million, compared with an ordinary loss of ¥22 million; and quarterly net loss attributable to owners of the parent was ¥39 million, compared with a quarterly net loss attributable to owners of the parent of ¥52 million. As of the end of the first quarter of the current consolidated fiscal year, the number of dispensing pharmacy outlets was 42, unchanged from the end of the previous consolidated fiscal year. The number of care facilities was 68, an increase of 1 from the end of the previous consolidated fiscal year. The number of operating childcare facilities was 78, an increase of 4 from the end of the previous consolidated fiscal year.」
First-quarter revenue was down 0.2% year on year, with an operating loss of ¥26 million, an ordinary loss of ¥27 million and a quarterly net loss attributable to owners of the parent of ¥39 million. The company had 42 dispensing pharmacies, 68 care facilities and 78 operating childcare facilities. - FY2023-Q3Updated performance and number of locationsAnnual report
「As a result, revenue was ¥16,533 million, up 18.3% year on year; operating income was ¥38 million, down 74.6%; ordinary income was ¥11 million, down 92.8%; and net loss attributable to owners of the parent was ¥58 million, compared with net income attributable to owners of the parent of ¥105 million in the same period of the previous year. At the end of the third quarter of the current consolidated fiscal year, the number of dispensing pharmacy stores was 42, an increase of 1 from the end of the previous consolidated fiscal year. At the end of the third quarter of the current consolidated fiscal year, the number of care offices and facilities was 68, unchanged from the end of the previous consolidated fiscal year. At the end of the third quarter of the current consolidated fiscal year, the number of operating offices was 83, an increase of 4 from the end of the previous consolidated fiscal year.」
Revenue increased 18.3% due in part to the contribution from life-support services, while operating profit declined 74.6% and ordinary profit declined 92.8%, resulting in a quarterly net loss attributable to owners of the parent of ¥58 million. The company had 42 dispensing pharmacies, 68 care facilities and 83 childcare facilities. - FY2023-Q2AdvancedAnnual report
「As a result, revenue was ¥10,931 million, up 28.2% year on year; operating income was ¥7 million, down 93.3%; ordinary loss was ¥11 million, compared with ordinary income of ¥128 million in the same period of the previous year; and net loss attributable to owners of the parent was ¥44 million, compared with net income attributable to owners of the parent of ¥82 million in the same period of the previous year. At the end of the second quarter of the current consolidated fiscal year, the number of dispensing pharmacy stores was 42, an increase of 1 from the end of the previous consolidated fiscal year. At the end of the second quarter of the current consolidated fiscal year, the number of care offices and facilities was 68, unchanged from the end of the previous consolidated fiscal year. At the end of the second quarter of the current consolidated fiscal year, the number of operating offices was 83, an increase of 4 from the end of the previous consolidated fiscal year.」
Revenue and the number of childcare offices increased during the cumulative second quarter, while operating income was ¥7 million, ordinary loss was ¥11 million, and net loss attributable to owners of the parent was ¥44 million. - FY2022AdvancedAnnual report
「As a result, revenue was ¥19,510 million, up 16.4% year on year; operating income was ¥186 million, down 42.2%; ordinary income was ¥189 million, down 44.2%; and net income attributable to owners of the parent was ¥291 million, down 39.0%. At the end of the current consolidated fiscal year, the number of dispensing pharmacy stores was 41, an increase of 1 from the end of the previous consolidated fiscal year. At the end of the current consolidated fiscal year, the number of care offices and facilities was 68, an increase of 7 from the end of the previous consolidated fiscal year. At the end of the current consolidated fiscal year, the number of operating offices was 79, an increase of 49 from the end of the previous consolidated fiscal year.」
Updated full-year performance and the number of locations. Revenue and the number of locations increased, while operating income, ordinary income and net income attributable to owners of the parent were below the previous year. - FY2022-Q3First statedAnnual report
「Revenue was ¥13,972 million, up 12.8% year on year; operating income was ¥153 million, down 5.0%; ordinary income was ¥167 million, down 6.2%; and net income attributable to owners of the parent was ¥105 million, down 13.7%. At the end of the third quarter of the current consolidated fiscal year, the number of dispensing pharmacy stores was 41, an increase of 1 from the end of the previous consolidated fiscal year. At the end of the third quarter of the current consolidated fiscal year, the number of care offices and facilities was 68, an increase of 7 from the end of the previous consolidated fiscal year. At the end of the third quarter of the current consolidated fiscal year, the number of operating offices was 84, an increase of 54 from the end of the previous consolidated fiscal year.」
Records consolidated performance and the number of locations in the pharmaceutical, care and childcare businesses as the initial benchmarks for tracking future changes.